RE:RE:New Press Release - Goldman Small Cap Research Publishes New Research Report on FSD Pharma, Inc. HUGE expects to receive a 7% royalty on UNBUZZD sales up to $250 million and then 3% from that point forward, with FSD retaining a 25% stake in Celly Nu until it reaches a $1 Billion market cap.